For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

2 September 2008
The August edition of Australian Prescriber includes articles on:
We must do better on rural cardiovascular disease
Death rates for cardiovascular disease are higher in country areas than in cities, and this could be caused by under prescribing of drugs for heart disease.
An editorial in the August edition of Australian Prescriber cites the lack of doctors as a major problem. Rural people see their GPs less and have less access to specialists, writes Professor Dawn DeWitt, head of the University of Melbourne School of Rural Health in Shepparton, Victoria.
Further work needed on new drugs for type 2 diabetes
Also in the August issue are reviews of exenatide and sitagliptin, recently approved for type 2 diabetes. The drugs can be added to treatment when diabetes is not controlled by other drugs.
The role of these incretin mimetics and enhancers is uncertain and requires further research, write Dr Anne Reutens and Associate Professor Jonathan Shaw from the Baker IDI Heart and Diabetes Institute in Melbourne.
'Exenatide mainly affects postprandial glucose, but it also lowers fasting glucose', say the authors. When it was compared with insulin, both drugs improved glycaemic control but the patients injecting exenatide lost weight.
Sitagliptin also improves glycaemic control but does not cause significant weight change, say Dr Reutens and Professor Shaw.
The new drugs are not without adverse effects. The article is accompanied by a review of the mechanisms of action of these drugs.
For the full August edition go to www.australianprescriber.com
ENDS
Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals, particularly doctors in general practice. It is published by the National Prescribing Service Limited (NPS), an independent, non-profit organisation for Quality Use of Medicines funded by the Australian Government Department of Health and Ageing.
Media enquiries
Contact us
Date published: 2008-09-02 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.